Yousefpour Noosha, Tansley Shannon N, Locke Samantha, Sharif Behrang, Parisien Marc, Bourojeni Farin B, Deamond Haley, Mathur Vidhu, Arana Nia Rahman-Khan, Austin Jean Sebastien, Bourassa Valerie, Wang Chengyang, Cabana Valérie C, Wong Calvin, Lister Kevin C, Rodrigues Rose, St-Louis Manon, Paquet Marie-Eve, Carroll Michael C, Andrews-Zwilling Yaisa, Seguela Philippe, Kania Artur, Yednock Ted, Mogil Jeffrey S, De Koninck Yves, Diatchenko Luda, Khoutorsky Arkady, Ribeiro-da-Silva Alfredo
Dept. of Pharmacology and Therapeutics, McGill University, Montréal, QC, Canada.
Alan Edwards Centre for Research on Pain, McGill University, Montréal, QC, Canada.
Nat Commun. 2025 May 17;16(1):4590. doi: 10.1038/s41467-025-59849-1.
Activation of spinal microglia following peripheral nerve injury is a central component of neuropathic pain pathology. While the contributions of microglia-mediated immune and neurotrophic signalling have been well-characterized, the phagocytic and synaptic pruning roles of microglia in neuropathic pain remain less understood. Here, we show that peripheral nerve injury induces microglial engulfment of dorsal horn synapses, leading to a preferential loss of inhibitory synapses and a shift in the balance between inhibitory and excitatory synapse density. This synapse removal is dependent on the microglial complement-mediated synapse pruning pathway, as mice deficient in complement C3 and C4 do not exhibit synapse elimination. Furthermore, pharmacological inhibition of the complement protein C1q prevents dorsal horn inhibitory synapse loss and attenuates neuropathic pain. Therefore, these results demonstrate that the complement pathway promotes persistent pain hypersensitivity via microglia-mediated engulfment of dorsal horn synapses in the spinal cord, revealing C1q as a therapeutic target in neuropathic pain.
外周神经损伤后脊髓小胶质细胞的激活是神经性疼痛病理的核心组成部分。虽然小胶质细胞介导的免疫和神经营养信号传导的作用已得到充分表征,但小胶质细胞在神经性疼痛中的吞噬和突触修剪作用仍不太清楚。在这里,我们表明外周神经损伤诱导小胶质细胞吞噬背角突触,导致抑制性突触优先丧失以及抑制性和兴奋性突触密度之间的平衡发生变化。这种突触清除依赖于小胶质细胞补体介导的突触修剪途径,因为缺乏补体C3和C4的小鼠没有表现出突触消除。此外,对补体蛋白C1q的药理学抑制可防止背角抑制性突触丧失并减轻神经性疼痛。因此,这些结果表明补体途径通过小胶质细胞介导的脊髓背角突触吞噬促进持续性疼痛超敏反应,揭示C1q作为神经性疼痛的治疗靶点。